Decoy Therapeutics Inc. Balance Sheet
DCOY|7 years of annual SEC 10-K data (FY2016-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Decoy Therapeutics Inc. had $15M in total assets and $39M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.1M | $29.2M | $11.1M | $3.7M | $9.8M | - | - |
| Accounts Receivable | - | - | - | - | $9.9K | $10.4K | $12.2K |
| Inventory | - | - | - | - | $186.9K | $431.9K | $454.1K |
| Current Assets | $14.5M | $30.2M | $15.8M | $4.7M | $10.3M | $34.5M | $62.5M |
| PP&E (Net) | - | $7.9K | $22.6K | $25.0K | $74.5K | $331.0K | $556.3K |
| Goodwill | - | $8.9M | $8.9M | $8.9M | - | - | - |
| Total Assets | $14.7M | $40.8M | $24.9M | $13.9M | $10.4M | $35.0M | $63.2M |
| Current Liabilities | - | - | - | - | $1.1M | $5.8M | $3.9M |
| Shareholders' Equity | $38.7M | $22.2M | $10.6M | -$1.3M | $29.1M | $92.2M | -$6.5M |